The Senior Manager, Business Assessment (BA) owns discrete commercial assessments and forecasts from end to end, building and defending the models and assumptions that inform investment decisions and external deal terms. The role independently evaluates internal pipeline and business development opportunities against Pfizer’s strategy and investment criteria, working closely with partners across Research & Development, Global Commercial Strategy, US and International commercial organizations, and Business Development. The Senior Manager is expected to work hands-on in the underlying models, apply consistent analytical rigor, provide strategic input on investment trade-offs, and present recommendations directly to executive governance bodies. The role is anchored in Inflammation & Immunology (I&I) and Specialty Care, covering areas such as respiratory, dermatology, gastroenterology, rheumatology, and rare cardiovascular disease. It also assesses opportunities in oncology, internal medicine, vaccines, emerging technology platforms, and novel modalities. The position is part of Pfizer’s Global Commercial Analytics organization under the Chief Marketing Office. The role uses AI tooling as a standard part of analytical work, including evidence and literature synthesis, competitive landscaping, model quality checks, code-assisted analysis, and drafting executive materials. Cycle-time gains are expected while maintaining rigor and traceability of assumptions. The position also scopes and manages qualitative and quantitative primary research, works flexibly across therapeutic areas in matrixed teams, and may support category, portfolio, and enterprise-level projects.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior